chloramphenicol has been researched along with sn 38 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Kamo, S; Kawasaki, T; Kuramochi, K; Kusakabe, Y; Mizutani, S; Takasawa, R; Tomoshige, S; Tsubaki, K; Yoshimoto, T | 1 |
2 review(s) available for chloramphenicol and sn 38
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
1 other study(ies) available for chloramphenicol and sn 38
| Article | Year |
|---|---|
Synthesis, antibacterial and cytotoxic evaluation of flavipucine and its derivatives.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacillus subtilis; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyridones; Structure-Activity Relationship | 2019 |